Nephrocare Health Services
add_icon

Nephrocare Health Services

562.95
+6.95
(1.25%)
Market Cap
5,648.68 Cr
PE Ratio
78.19
Volume
27,546.00
Day High - Low
573.85 - 546.95
52W High-Low
603.80 - 446.00
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
5,648.68 Cr
EPS
8.28
PE Ratio
78.19
PB Ratio
5.14
Book Value
90.58
EBITDA
180.70
Dividend Yield
0.00 %
Return on Equity
11.49
Debt to Equity
0.53
Forecast For
Actual
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,431.60
#1 23,986.60
44.70
#1 2,554.80
11.28
#1 492
-6.83
48.89
1,018.25
10,459.97
64.84
699.70
23.06
144
22.38
54.52
1,929.20
9,997.50
59.24
1,346.30
10.64
146
33.65
51.03
414.30
6,594.07
47.68
702.20
20.80
91
47.37
41.10
562.95
#5 5,648.68
#10 78.19
#4 769.90
#2 33.97
#6 67
#4 60.20
61.79
672.40
2,181.18
26.87
742.70
16.70
78
-21.13
32.82
774.50
1,513.60
24.59
147.80
#1 134.60
19
#1 520.00
75.94
283.45
1,476.23
45.74
255.90
15.11
31
20.00
60.11
1,595.00
1,368.90
#1 23.40
111.60
28.72
48
65.93
50.23
290.00
922.50
32.79
1,170.80
-18.47
-134
101.06
47.24

Automatic Screeners on ScanX

Growth Rate
Revenue Growth
33.97 %
Net Income Growth
91.17 %
Cash Flow Change
87.26 %
ROE
35.34 %
ROCE
60.40 %
EBITDA Margin (Avg.)
23.32 %

Quarterly Financial Results

Quarterly Financials
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Revenue
203
223
234
250
263
Expenses
153
168
180
182
199
EBITDA
50
55
54
68
64
Operating Profit %
22 %
23 %
21 %
26 %
23 %
Depreciation
18
19
20
23
22
Interest
5
6
6
45
6
Profit Before Tax
26
30
29
-1
36
Tax
6
5
5
9
4
Net Profit
20
25
24
-10
32
EPS in ₹
2.47
140.89
13.10
-1.12
3.43

Balance Sheet

Balance Sheet
2021
2022
2023
2024
2025
Total Assets
428
571
666
806
997
Fixed Assets
192
205
239
356
396
Current Assets
178
285
324
390
545
Capital Work in Progress
2
43
34
1
6
Investments
0
0
0
0
51
Other Assets
234
322
393
450
544
Total Liabilities
428
571
666
806
997
Current Liabilities
94
94
175
243
284
Non Current Liabilities
75
81
103
150
129
Total Equity
259
396
389
414
584
Reserve & Surplus
245
387
384
409
579
Share Capital
4
5
5
2
2

Cash Flow

Cash Flow
2021
2022
2023
2024
2025
Net Cash Flow
5
6
-5
47
65
Investing Activities
-62
-130
-76
-52
-125
Operating Activities
32
14
11
72
135
Financing Activities
36
121
60
27
54

Share Holding

% Holding
Jul 2025
Dec 2025
Promoter
79.05 %
63.85 %
FIIs
0.00 %
9.30 %
DIIs
0.00 %
8.10 %
Government
0.00 %
0.00 %
Public / Retail
0.00 %
5.92 %
Others
20.94 %
12.82 %
No of Share Holders
65
36

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
10 Feb 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
10 Feb 2026 512.90 527.50

Announcements

Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements4 days ago
Announcement under Regulation 30 (LODR)-Monitoring Agency Report4 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome5 days ago
Announcement under Regulation 30 (LODR)-Investor Presentation6 days ago
Announcement under Regulation 30 (LODR)-Press Release / Media Release6 days ago
Announcement under Regulation 30 (LODR)-Change in Management6 days ago
Board Meeting Outcome for Outcome Of The Board Meeting Held On February 10 20266 days ago
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report9 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 30, 2026
Board Meeting Intimation for Considering And Approving Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended 31St December 2025.Jan 30, 2026
Announcement under Regulation 30 (LODR)-Memorandum of Understanding /AgreementsJan 27, 2026
Issuance Of Corporate Guarantee For And On Behalf Of Nephrocare Health Care Services Philippines Inc. Philippines Step-Down Wholly-Owned Subsidiary Not Exceeding USD 6.00 Million. Jan 15, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 15, 2026
We Would Like To Inform That Pursuant To The Listing Of Equity Shares Of The Company On The Recognized Stock Exchanges Namely BSE Limited And National Stock Exchange Of India Limited The CIN Of The Company Has Been Changed From U85100TG2009PLC066359 To L8Jan 15, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 08, 2026
Shareholder Meeting / Postal Ballot-Notice of Postal BallotJan 07, 2026
Shareholder Meeting / Postal Ballot-Notice of Postal BallotJan 07, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementJan 05, 2026
Closure of Trading WindowDec 29, 2025
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Dec 23, 2025
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Dec 23, 2025
Appointment of Company Secretary and Compliance OfficerDec 22, 2025
Intimation Under Reg 8(2) Of SEBI (PIT) Reg 2015 Enclosed Is The Code Of Practices And Procedures For Fair Disclosure Of Unpublished Price Sensitive Information.Dec 22, 2025
Intimation Under Regulation 30(5) Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulation 2015Dec 22, 2025
Listing of Equity Shares of Nephrocare Health Services LtdDec 17, 2025

Technical Indicators

RSI(14)
Neutral
61.79
ATR(14)
Volatile
23.44
STOCH(9,6)
Neutral
67.65
STOCH RSI(14)
Neutral
60.46
MACD(12,26)
Bullish
4.70
ADX(14)
Strong Trend
38.28
UO(9)
Bearish
51.28
ROC(12)
Uptrend And Accelerating
5.36
WillR(14)
Neutral
-48.65